| Financial Year |
March 31 2023 |
| Monetary Funds |
13,304,486,481.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
886,100,791.60 |
| Advances to Suppliers |
461,549,919.30 |
| Other Receivables |
7,293,176,276.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
73,181,891,118.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,083,880,194.20 |
| Total Current Assets |
106,211,084,781.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,275,270,834.31 |
| Investment Properties |
39,461,645,414.61 |
| Fixed Assetes |
2,484,082,694.61 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
381,662,390.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,494,729,776.32 |
| Other Non-Current Assets |
321,579,012.62 |
| Sub-Total of Non-Current Assets |
50,339,826,788.11 |
| Total Assets |
156,550,911,569.12 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
116,389,012.37 |
| Accounts Payable |
7,141,472,004.19 |
| Accounts Received In Advance |
196,816,590.79 |
| Employee Compensation Payable |
204,173,885.87 |
| Taxes Payable |
2,029,784,409.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,076,334,512.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,413,920,008.31 |
| Other Current Liabilities |
959,240,008.33 |
| Sub-Total of Current Liabilities |
36,509,362,711.81 |
| Long-term Loans |
46,705,448,281.09 |
| Bonds Payable |
27,089,961,239.45 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,942,499,044.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
77,853,662,676.77 |
| Total Liabilities |
114,363,025,388.58 |
| Paid-In Capital(Or Share Stock) |
2,988,929,907.00 |
| Capital Surplus |
6,939,918,297.92 |
| Surplus Reserve |
1,494,464,953.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
25,546,586,100.68 |
| Minority Stockholder's Interest |
4,470,542,058.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
37,717,344,122.11 |
| Owner's Equity（Stockholder's Equity） |
42,187,886,180.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
156,550,911,569.12 |
